VALO OPAL COMPUTATIONAL PLATFORM Trademark

Trademark Overview


On Tuesday, September 15, 2020, a trademark application was filed for VALO OPAL COMPUTATIONAL PLATFORM with the United States Patent and Trademark Office. The USPTO has given the VALO OPAL COMPUTATIONAL PLATFORM trademark a serial number of 90181491. The federal status of this trademark filing is SUBSEQUENT FINAL MAILED as of Saturday, January 6, 2024. This trademark is owned by Valo Health, LLC. The VALO OPAL COMPUTATIONAL PLATFORM trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

downloadable and recorded software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; software as a service for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials
valo opal computational platform

General Information


Serial Number90181491
Word MarkVALO OPAL COMPUTATIONAL PLATFORM
Filing DateTuesday, September 15, 2020
Status660 - SUBSEQUENT FINAL MAILED
Status DateSaturday, January 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesdownloadable and recorded software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement
NOT AVAILABLE"COMPUTATIONAL PLATFORM"
Goods and ServicesResearch and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; software as a service for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, July 27, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 27, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameValo Health, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Wednesday, October 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 11, 2021NON-FINAL ACTION E-MAILED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Thursday, February 11, 2021NON-FINAL ACTION WRITTEN
Thursday, February 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 29, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 25, 2021SUSPENSION LETTER WRITTEN
Wednesday, August 25, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, August 25, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, May 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 5, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, January 4, 2023FINAL REFUSAL WRITTEN
Wednesday, January 4, 2023FINAL REFUSAL E-MAILED
Wednesday, January 4, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 22, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, February 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 24, 2023SUSPENSION LETTER WRITTEN
Friday, March 24, 2023LETTER OF SUSPENSION E-MAILED
Friday, March 24, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 14, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, January 6, 2024SUBSEQUENT FINAL EMAILED
Saturday, January 6, 2024SUBSEQUENT FINAL REFUSAL WRITTEN
Saturday, January 6, 2024NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, June 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 28, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, March 28, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED